Who owns Trevi Therapeutics Inc?
- Ticker: TRVI
- CUSIP Number: 89532m101
Tip: Access positions for across all investors
Analyze quarterly positions in Trevi Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Trevi Therapeutics stock
Who bought or sold Trevi Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 11M | $39M | 0% | Mar 2024 |
|
| Frazier Life Sciences Management | 7.4M | $26M | 0% | Mar 2024 |
|
| Rubric Capital Management | 5.6M | $19M | -2% | Mar 2024 |
|
| Viking Global Investors | 4.4M | $15M | 0% | Mar 2024 |
|
| VR Adviser | 3.4M | $12M | 0% | Mar 2024 |
|
| Opaleye Management | 2.6M | $9.1M | 4% | Mar 2024 |
|
| BlackRock | 2.4M | $8.2M | 11% | Mar 2024 |
|
| Vanguard Group | 2.3M | $7.9M | 3% | Mar 2024 |
|
| Logos Global Management | 2.2M | $7.6M | 100% | Mar 2024 |
|
| MPM Oncology Impact Management | 1.3M | $4.6M | 100% | Mar 2024 |
|
| MAI Wealth Advisors | 1.1M | $3.9M | -12% | Mar 2024 |
|
| Rosalind Advisors | 926k | $3.2M | -50% | Mar 2024 |
|
| Geode Capital Management | 898k | $3.1M | 14% | Mar 2024 |
|
| Landscape Capital Management | 740k | $2.6M | -19% | Mar 2024 |
|
| Checkpoint Capital | 506k | $1.7M | -61% | Mar 2024 |
|
| Northern Trust | 328k | $1.1M | 4% | Mar 2024 |
|
| Propel Bio Management | 260k | $897k | 100% | Mar 2024 |
|
| Simplify Asset Management | 200k | $690k | 100% | Mar 2024 |
|
| J. Goldman & Co | 138k | $476k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 129k | $444k | -4% | Mar 2024 |
|
| Shay Capital | 114k | $392k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 108k | $372k | 0% | Mar 2024 |
|
| PFS Partners | 99k | $342k | 0% | Mar 2024 |
|
| Bridgeway Capital Management | 97k | $333k | -48% | Mar 2024 |
|
| Nuveen Asset Management | 75k | $258k | 12% | Mar 2024 |
|
| Morgan Stanley | 68k | $235k | 97% | Mar 2024 |
|
| Wealthtrust Axiom | 64k | $219k | 0% | Mar 2024 |
|
| Oppenheimer & Co | 60k | $208k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 52k | $179k | 1% | Mar 2024 |
|
| American Century Companies | 46k | $159k | 116% | Mar 2024 |
|
| UBS Group | 42k | $145k | 34% | Mar 2024 |
|
| Bailard | 41k | $141k | 100% | Mar 2024 |
|
| Goldman Sachs Group | 38k | $131k | 59% | Mar 2024 |
|
| Tejara Capital | 38k | $129k | -97% | Mar 2024 |
|
| Trust Co Of Toledo Na | 37k | $126k | 0% | Mar 2024 |
|
| LPL Financial | 36k | $124k | 100% | Mar 2024 |
|
| Barclays | 35k | $122k | -45% | Mar 2024 |
|
| Citadel Advisors | 32k | $109k | -83% | Mar 2024 |
|
| United Bank | 29k | $98k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 26k | $88k | -6% | Mar 2024 |
|
| Dimensional Fund Advisors | 23k | $78k | 100% | Mar 2024 |
|
| Bank of America Corporation | 22k | $76k | -48% | Mar 2024 |
|
| Ameriprise Financial | 22k | $75k | 100% | Mar 2024 |
|
| American International | 21k | $28k | 1% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 21k | $71k | -84% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 18k | $62k | 100% | Mar 2024 |
|
| Jane Street | 17k | $59k | -74% | Mar 2024 |
|
| Wells Fargo & Company | 17k | $58k | 30% | Mar 2024 |
|
| New York State Common Retirement Fund | 15k | $52k | -59% | Mar 2024 |
|
| Squarepoint Ops | 15k | $52k | -85% | Mar 2024 |
|
| SG Americas Securities | 15k | $50k | -85% | Mar 2024 |
|
| T. Rowe Price Associates | 14k | $47k | 100% | Mar 2024 |
|
| Ing Investment Management | 13k | $46k | -24% | Mar 2024 |
|
| Stifel Financial | 10k | $34k | 0% | Mar 2024 |
|
| Raymond James & Associates | 10k | $35k | 100% | Mar 2024 |
|
| Citigroup | 8.7k | $30k | 25% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 8.2k | $28k | -6% | Mar 2024 |
|
| California State Teachers Retirement System | 4.2k | $15k | -54% | Mar 2024 |
|
| Legal & General Group | 4.0k | $14k | 0% | Mar 2024 |
|
| FMR | 3.5k | $12k | 124% | Mar 2024 |
|
| Summit Investment Advisors | 3.4k | $12k | 0% | Mar 2024 |
|
| Nbc Securities | 2.0k | $6.0k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 1.5k | $5.6k | -90% | Mar 2024 |
|
| Amalgamated Bank | 1.4k | $5.0k | -61% | Mar 2024 |
|
| Federated Investors | 950.00 | $1.3k | 100% | Dec 2023 |
|
| Tower Research Capital | 610.00 | $2.1k | -91% | Mar 2024 |
|
| Farther Finance Advisors | 55.00 | $184.998000 | 100% | Mar 2024 |
|
| Steward Partners Investment Advisory | 25.00 | $86.000000 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 6.00 | $19.999800 | 100% | Mar 2024 |
|
| CWM | 3.00 | $0 | 100% | Mar 2024 |
|
| NISA Investment Advisors | 3.00 | $9.999900 | 100% | Mar 2024 |
|
Who sold out of Trevi Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tang Capital Management | Dec 2023 | 300k | $402k |
| Millennium Management | Dec 2023 | 120k | $161k |
| Florida State Board of Administration | Dec 2023 | 11k | $15k |